Company / Income Tax per Share
Edgewise Therapeutics, Inc. Income Tax per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2025
5-year range
$0.00 / $0.00
FY2021-FY2025
Trend
+19.7%
vs FY2024
Sector context
#112 of 201
Health Care
What the data says
At $0.00, Edgewise Therapeutics, Inc.'s income tax per share ranks #90 of 201 in the Health Care sector. Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 201 in Health CareTop 44% of 201This company $0.00 Sector average $1.35
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 19.7% year-over-year.
- Ranks #112 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2023.
- Lowest income tax per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +19.7% |
| FY2024 | $0.00 | -48.3% |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026